3-hydroxybutyric acid has been researched along with Dyslipidemias in 3 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity is a global health problem caused by genetic, environmental, and psychological factors and is associated with various health disorders." | 1.91 | Prebiotic effect of poly-D-3-hydroxybutyrate prevents dyslipidemia in obese mice. ( Aihara, N; Kamiie, J; Mishima, M; Mizugaki, H; Nagane, M; Ogata, M; Okamatsu-Ogura, Y; Satoh, T; Shima, A; Suzuki, R; Suzuki, T; Takeda, S; Yamashita, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mishima, M | 1 |
| Takeda, S | 1 |
| Nagane, M | 1 |
| Suzuki, T | 1 |
| Ogata, M | 1 |
| Shima, A | 1 |
| Aihara, N | 1 |
| Kamiie, J | 1 |
| Suzuki, R | 1 |
| Mizugaki, H | 1 |
| Okamatsu-Ogura, Y | 1 |
| Satoh, T | 1 |
| Yamashita, T | 1 |
| Pikija, S | 1 |
| Trkulja, V | 1 |
| Simundic, AM | 1 |
| Vrcek, E | 1 |
| Boskovic, K | 1 |
| Bacani, S | 1 |
| Li, D | 1 |
| Zhang, Y | 1 |
| Liu, Y | 1 |
| Sun, R | 1 |
| Xia, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Purified Anthocyanin on Oxidative Stress and Glycemic Control in Subjects With Type 2 Diabetes Mellitus: A Randomized, Double-Blinded, Placebo-Controlled Trial[NCT02317211] | Early Phase 1 | 70 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 3-hydroxybutyric acid and Dyslipidemias
| Article | Year |
|---|---|
Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients.
Topics: 3-Hydroxybutyric Acid; Aged; Anthocyanins; Antioxidants; Apolipoprotein B-48; Apolipoprotein C-III; | 2015 |
2 other studies available for 3-hydroxybutyric acid and Dyslipidemias
| Article | Year |
|---|---|
Prebiotic effect of poly-D-3-hydroxybutyrate prevents dyslipidemia in obese mice.
Topics: 3-Hydroxybutyric Acid; Animals; Bacteria; Diet, High-Fat; Dyslipidemias; Mice; Mice, Inbred C57BL; M | 2023 |
Is on-admission capillary blood beta-hydroxybutyrate concentration associated with the acute stroke severity and short-term functional outcome?
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Aged, 80 and over; Brain Ischemia; Capillaries; Diabetes Complic | 2013 |